- Brand IP Statement(s) re: (c), (TM), (SM)
- Proven to impact health in more than 30 trials and studies, Vitaline(R) CoQ10's patent-pending formulation offers a fact base of efficacy and safety.
- General Statements: All Other Content
- Vitaline CoQ10 has been the CoQ10 of choice in National Institute of Health (NIH) research.
- Brand IP Statement(s) re: (c), (TM), (SM)
- ITI(R) evidence-based natural medicines are the only choice of doctors who rely on the fact base of premier science to deliver patient results.
- Suggested/Recommended/Usage/Directions
- Recommendations: Adults chew four or more wafers daily or as directed by your healthcare practitioner.
- General: Product/Version Code
- LI76186.03
- FDA Disclaimer Statement
- THIS STATEMENT HAS NOT BEEN EVALUATED BY THE FOOD AND DRUG ADMINISTRATION. THIS PRODUCT IS NOT INTENDED TO DIAGNOSE, TREAT, CURE, OR PREVENT ANY DISEASE.
- General Statements: All Other Content
- PREMIER SCIENCE
- General Statements: All Other Content
- Subject of over 30 clinical trials & studies, including the NIH clinicals
- FDA Statement of Identity
- Dietary Supplement
- Precautions re: Pregnant or Nursing or Prescription Medications
- If pregnant, nursing, or taking prescription drugs, consult your healthcare practitioner prior to use.
- Formulation re: Does NOT Contain
- Contains no sucrose, salt, yeast, wheat, gluten, corn, soy, dairy products, artificial coloring, artificial flavoring, or preservatives.
- General Statements: All Other Content